Shu Y - Search Results

1

A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.

Qian J, Qian Y, Wang J, Gu B, Pei D, He S, Zhu F, Røe OD, Xu J, Liu L, Gu Y, Guo R, Yin Y, Shu Y, Chen X. Qian J, et al. Among authors: shu y. Drug Des Devel Ther. 2016 Feb 24;10:241-58. doi: 10.2147/DDDT.S88743. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 26966350 Free PMC article.

2

The effect of dendritic cells activated by OK-432 and pulsed with antigens on cytokine induced killers.

Shu YQ, Gu Y. Shu YQ, et al. Biomed Pharmacother. 2006 May;60(4):156-60. doi: 10.1016/j.biopha.2006.03.001. Epub 2006 Mar 31. Biomed Pharmacother. 2006. PMID: 16647239

3

[Immunomodulatory effects of spleenic cells added by sIL-15Ralpha on the regulation of melanoma cell growth].

Gu YH, Wang RS, Shu YQ, Xu Q. Gu YH, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008 Sep;24(9):847-9. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008. PMID: 18782512 Chinese.

4

A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.

Gu Y, Shu Y, Xu Q. Gu Y, et al. Among authors: shu y. Biomed Pharmacother. 2009 May;63(4):293-6. doi: 10.1016/j.biopha.2008.08.018. Epub 2008 Sep 17. Biomed Pharmacother. 2009. PMID: 18848761 Clinical Trial.

5

Tamoxifen inhibits proliferation and induces apoptosis in human hepatocellular carcinoma cell line HepG2 via down-regulation of survivin expression.

Guo R, Huang Z, Shu Y, Jin S, Ge H. Guo R, et al. Among authors: shu y. Biomed Pharmacother. 2009 Jun;63(5):375-9. doi: 10.1016/j.biopha.2008.09.010. Epub 2008 Oct 23. Biomed Pharmacother. 2009. PMID: 18993026

6

The property of methylated APC gene promotor and its influence on lung cancer cell line.

Pan S, Zhang L, Gao L, Gu B, Wang F, Xu J, Shu Y, Yang D, Chen Z. Pan S, et al. Among authors: shu y. Biomed Pharmacother. 2009 Aug;63(7):463-8. doi: 10.1016/j.biopha.2008.09.006. Epub 2008 Oct 23. Biomed Pharmacother. 2009. PMID: 18996677

7

[Insulin/PI3K signalling pathway regulates the expression of survivin in liver cancer HepG2 cells].

Guo RH, Jin SD, Cai J, Huang ZH, Shu YQ. Guo RH, et al. Zhonghua Zhong Liu Za Zhi. 2008 Oct;30(10):745-8. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173802 Chinese.

8

JNK/AP-1 pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells.

Yin Y, Wang S, Sun Y, Matt Y, Colburn NH, Shu Y, Han X. Yin Y, et al. Among authors: shu y. Biomed Pharmacother. 2009 Jul;63(6):429-35. doi: 10.1016/j.biopha.2009.04.045. Epub 2009 Jun 9. Biomed Pharmacother. 2009. PMID: 19553068 Free PMC article.

9

Gene expression of the invasive phenotype of TNF-alpha-treated MCF-7 cells.

Yin Y, Chen X, Shu Y. Yin Y, et al. Among authors: shu y. Biomed Pharmacother. 2009 Jul;63(6):421-8. doi: 10.1016/j.biopha.2009.04.032. Epub 2009 Jun 13. Biomed Pharmacother. 2009. PMID: 19564093

10

Involvement of mTOR and survivin inhibition in tamoxifen-induced apoptosis in human hepatoblastoma cell line HepG2.

Guo R, Wang T, Shen H, Ge HM, Sun J, Huang ZH, Shu YQ. Guo R, et al. Biomed Pharmacother. 2010 Apr;64(4):249-53. doi: 10.1016/j.biopha.2009.06.007. Epub 2009 Oct 22. Biomed Pharmacother. 2010. PMID: 19931998

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,925 results

Search Page

Filters